Acura Pharmaceuticals Inc. (NASDAQ:ACUR)

CAPS Rating: 2 out of 5

A pharmaceutical company engaged in research, development and manufacture of innovative Aversion(r) Technology and related product candidates.

Recs

0
Player Avatar Lcrazylegs84 (< 20) Submitted: 10/1/2011 1:06:09 AM : Outperform Start Price: $3.50 ACUR Score: -38.67

going up

Report this Post Reply

Featured Broker Partners


Advertisement